Opendata, web and dolomites

Secreters SIGNED

A new generation of microbial expression hosts and tools for the production of biotherapeutics and high-value enzymes

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Secreters project word cloud

Explore the words cloud of the Secreters project. It provides you a very rough idea of what is the project "Secreters" about.

thrive    billion    poised    synthetic    bonded    beneficiaries    responsible    140    microbial    academic    diseases    yeast    biotherapeutic    interdisciplinary    species    ranging    patient    industrial    industry    escherichia    trained    producing    protein    chemistry    intersectoral    powerful    super    categories    combined    engage    redox    superbly    foci    treatment    team    15    bacillus    pichia    permeate    generation    daily    ing    biotechnology    critical    train    excess    latter    lower    partnership    life    coli    premier    expertise    recombinant    express    format    severe    hosts    difficult    proteins    commitment    skills    pastoris    whereas    quality    biology    pose    innovation    former    training    scientists    equip    expression    entrepreneurial    enzymes    innovations    secreters    medicines    outreach    world    close    series    enzyme    companies    sectors    capitalises    industries    markets    esrs    clear    disulphide    assurance    drugs    biotherapeutics   

Project "Secreters" data sheet

The following table provides information about the project.

Coordinator
ACADEMISCH ZIEKENHUIS GRONINGEN 

Organization address
address: HANZEPLEIN 1
city: GRONINGEN
postcode: 9713 GZ
website: www.umcg.nl

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Total cost 4˙087˙420 €
 EC max contribution 4˙087˙420 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2018
 Funding Scheme MSCA-ITN-ETN
 Starting year 2019
 Duration (year-month-day) from 2019-01-01   to  2022-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ACADEMISCH ZIEKENHUIS GRONINGEN NL (GRONINGEN) coordinator 531˙239.00
2    UNIVERSITY OF KENT UK (CANTERBURY, KENT) participant 606˙345.00
3    OULUN YLIOPISTO FI (OULU) participant 561˙611.00
4    ACIB GMBH AT (GRAZ) participant 528˙414.00
5    CELLTECH R&D LIMITED UK (SLOUGH) participant 303˙172.00
6    LONZA AG CH (BASEL) participant 281˙276.00
7    BOEHRINGER INGELHEIM RCV GMBH & CO KG AT (WIEN) participant 264˙207.00
8    AB Enzymes GmbH DE (Darmstadt) participant 252˙788.00
9    HUMBOLDT-UNIVERSITAET ZU BERLIN DE (BERLIN) participant 252˙788.00
10    UNIVERSITAET GREIFSWALD DE (GREIFSWALD) participant 252˙788.00
11    UNIVERSITATSMEDIZIN GREIFSWALD KORPERSCHAFT DES OFFENTLICHEN RECHTS DE (GREIFSWALD) participant 252˙788.00
12    UCB PHARMA SA BE (BRUXELLES) participant 0.00
13    BIOMIN HOLDING GMBH AT (GETZERSDORF BEI TRAISMAUER) partner 0.00
14    Gedeon Richter Plc. HU (Budapest) partner 0.00
15    POLYMUN SCIENTIFIC IMMUNBIOLOGISCHE FORSCHUNG GMBH AT (KLOSTERNEUBURG) partner 0.00
16    UNIVERSITAET FUER BODENKULTUR WIEN AT (WIEN) partner 0.00

Map

 Project objective

The ‘SECRETERS’ partnership aims to bring about a step change in the production of recombinant proteins, particularly Biotherapeutics and Industrial Enzymes. Both are critical products for the EU biotechnology sector, with combined markets in excess of $140 billion p.a.; the former are essential for the treatment of major diseases whereas the latter permeate every aspect of our daily life. Many proteins in these categories pose severe problems in production, especially disulphide-bonded proteins and new format 'difficult-to-express' proteins. SECRETERS will train a team of 15 ESRs to develop a new generation of super-producing microbial production hosts, including Escherichia coli, Bacillus species and the yeast Pichia pastoris. The project capitalises on a series of recent innovations and involves close collaboration between 5 academic Beneficiaries, who provide world-leading expertise in redox chemistry, synthetic biology and protein expression, and 5 non-academic Beneficiaries, who include some of the world's premier biotherapeutic and industrial enzyme companies. It will enable the biotherapeutics industry to produce challenging medicines at lower costs, resulting in new drugs and wider patient access, and allow the enzymes industry to deliver a range of powerful new products. SECRETERS will equip ESRs with the interdisciplinary and intersectoral skills required to thrive in these industries, with quality assurance systems embedded throughout the programme and a commitment to a wide-ranging dissemination/outreach programme. Based on a responsible innovation approach, with clear foci on research and entrepreneurial training, SECRETERS will deliver a team of superbly-trained scientists, poised to engage in some of Europe's most important biotechnology sectors.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SECRETERS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SECRETERS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

BIGMATH (2018)

Big Data Challenges for Mathematics

Read More  

DESIGN-EID (2020)

Defect Simulation and Material Growth of III-V Nanostructures- European Industrial Doctorate Program

Read More  

NanoCarb (2018)

Glyco-Nanoparticles for Applications in Advance Nanomedicine

Read More